Tim-3 on peripheral CD4+ and CD8+ T cells is involved in the development of glioma

DNA and Cell Biology

Volumn 33, Issue 4, 2014, Pages 245-250

  Han, Song ^a,b   Feng, Sizhe ^b   Xu, Lunshan ^a   Shi, Weiwei ^c   Wang, Xuhui ^a   Wang, Hao ^a   Yu, Chunyong ^b   Dong, Tao ^b   Xu, Minhui ^a   Liang, Guobiao ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; TIM 3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FUNCTIONAL DISEASE; GLIOMA; HUMAN; HUMAN CELL; KARNOFSKY PERFORMANCE STATUS; LEUKOCYTE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURFACE PROPERTY; SURVIVAL TIME;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHINA; FLOW CYTOMETRY; GLIOMA; HUMANS; IMMUNE TOLERANCE; MEMBRANE PROTEINS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897397411     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2306     Document Type: Article

References (21)

1. Anderson, A.C., Anderson, D.E., Bregoli, L., Hastings, W.D., Kassam, N., Lei, C., et al. (2007). Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318, 1141-1143.
2. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-324.
3. Bethke, L., Webb, E., Murray, A., Schoemaker, M., Johansen, C., Christensen, H.C., et al. (2008). Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 17, 800-805.
4. Chae, S.C., Park, Y.R., Shim, S.C., Yoon, K.S., and Chung, H.T. (2004). The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett 95, 91-95.
5. Frisancho-Kiss, S., Nyland, J.F., Davis, S.E., Barrett, M.A., Gatewood, S.J., Njoku, D.B., et al. (2006). Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 176, 6411-6415.
6. Hou, S.X., Ding, B.J., Li, H.Z., Wang, L., Xia, F., Du, F., et al. (2013). Identification of microRNA-205 as a potential prognostic indicator for human glioma. J Clin Neurosci 20, 933-937.
7. Ju, Y., Hou, N., Meng, J., Wang, X., Zhang, X., Zhao, D., et al. (2010). T cell immunoglobulin-andmucin-domaincontaining molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 52, 322-329.
8. Khademi, M., Illés, Z., Gielen, A.W., Marta, M., Takazawa, N., Baecher-Allan, C., et al. (2004). T cell Ig-and mucindomaincontaining molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 172, 7169-7176.
9. Koguchi, K., Anderson, D.E., Yang, L., O'Connor, K.C., Kuchroo, V.K., and Hafler, D.A. (2006). Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 203, 1413-1418.
10. Liu, Y., Shete, S., Hosking, F., Robertson, L., Houlston, R., and Bondy, M. (2010). Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev 20, 239-244.
11. Monney, L., Sabatos, C.A., Gaglia, J.L., Ryu, A., Waldner, H., Chernova, T., et al. (2002). Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536-541.
12. Naka, S., Iikura, M., Suto, H., Akiba, H., Umetsu, D.T., Dekruyff, R.H., et al. (2007). TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110, 2565-2568.
13. Prevoo, M.L., van't Hof, M.A., Kuper, H.H., van Leeuwen, M.A., van de Putte, L.B., and van Riel, P.L. (1995). Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38, 44-48.
14. Sánchez-Fueyo, A., Tian, J., Picarella, D., Domenig, C., Zheng, X.X., Sabatos, C.A., et al. (2003). Tim-3 inhibits T helper type 1-mediated auto-and alloimmune responses and promotes immunological tolerance. Nat Immunol 4, 1093-1101.
15. Seki, M., Oomizu, S., Sakata, K.M., Sakata, A., Arikawa, T., Watanabe, K., et al. (2008). Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127, 78-88.
16. Shete, S., Hosking, F.J., Robertson, L.B., Dobbins, S.E., Sanson, M., Malmer, B., et al. (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41, 899-904.
17. Wang, L., He, S., Tu, Y., Ji, P., Zong, J., Zhang, J., et al. (2013). Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma. J Clin Neurosci 20, 958-963.
18. Wiemels, J.L., Wiencke, J.K., Patoka, J., Moghadassi, M., Chew, T., McMillan, A., et al. (2004). Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 64, 8468-8473.
19. Wrensch, M., Jenkins, R.B., Chang, J.S., Yeh, R.F., Xiao, Y., Decker, P.A., et al. (2009). Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41, 905-908.
20. Wu, J., Liu, C., Qian, S., Hou, H. (2013). The expression of Tim-3 in peripheral blood of ovarian cancer. DNA Cell Biol 32, 648-653.
21. Zhu, C., Anderson, A.C., Schubart, A., Xiong, H., Imitola, J., Khoury, S.J., et al. (2005). The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6, 1245-1252.